These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23568750)

  • 1. Questionable conclusions in the article "Cardiovascular toxicity of Citrus aurantium in exercised rats".
    Stohs SJ
    Cardiovasc Toxicol; 2013 Jun; 13(2):180-1. PubMed ID: 23568750
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular toxicity of Citrus aurantium in exercised rats.
    Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
    Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
    Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
    Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to letter to the editor.
    Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
    Cardiovasc Toxicol; 2013 Jun; 13(2):182-3. PubMed ID: 23589039
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
    Shara M; Stohs SJ; Mukattash TL
    Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
    Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
    Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
    Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
    Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
    Haller CA; Benowitz NL; Jacob P
    Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cardiovascular effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine in human subjects: A placebo-controlled, double-blind study.
    Ratamess NA; Bush JA; Stohs SJ; Ellis NL; Vought IT; O'Grady EA; Kuper JD; Hasan SB; Kang J; Faigenbaum AD
    Phytother Res; 2018 Jan; 32(1):94-102. PubMed ID: 29047215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
    Pellati F; Benvenuti S
    J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat.
    Ilbäck NG; Siller M; Stålhandske T
    Food Chem Toxicol; 2007 May; 45(5):834-42. PubMed ID: 17175084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on heart rate of bitter orange, caffeine, and exercise.
    McGuffin M
    Am J Med; 2007 Jan; 120(1):e19; author reply e21. PubMed ID: 17208064
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of essential oil from Citrus aurantium in maternal reproductive outcome and fetal anomaly frequency in rats.
    Volpato GT; Francia-Farje LA; Damasceno DC; Oliveira RV; Hiruma-Lima CA; Kempinas WG
    An Acad Bras Cienc; 2015 Mar; 87(1):407-15. PubMed ID: 25806990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.